This is a free preview of a paid episode. To hear more, visit
www.mendelspod.comOne might think the pandemic would have been good for diagnostic companies. So why the financial hangover?Mara Aspinall has 30 years of leadership in genomics and the diagnostics industry. This has led her to her current role as a new partner at Illumina Ventures, a venture fund independent from Illumina that is focused on funding diagnostics and tools companies.Mara publishes the fantastic newsletter Sensitive and Specific and also a yearly report on industry trends, which is the topic of our show today. We discuss valuations, new regulations, and the latest science. Mara co-founded the Biomedical Diagnostics master’s degree program at Arizona State University, the only program dedicated exclusively to diagnostics, genetics, and genomics. How is the program faring, and how are we doing as a nation in educating the next generation on a revolution in diagnostic testing?
